Monday, January 05, 2026

 

Greenland shark study may lead to new ways to preserve vision as we age



UC Irvine research finds DNA mechanism enabling these sharks to maintain vision over centuries




University of California - Irvine





Irvine, Calif., Jan. 5, 2026 — Dorota Skowronska-Krawczyk sits in her office, eyes fixed on the computer monitor in front of her.

“You see it move its eye,” says the UC Irvine associate professor of physiology and biophysics, pointing to an image of a Greenland shark slowly drifting through the murky Arctic Ocean. “The shark is tracking the light – it’s fascinating.”

The video shows the longest-living vertebrate in the world – long, thick, grey body; small head; and short, rounded snout – with opaque eyes that appear lifeless, except for the parasite latched to one of its eyeballs. Scientists have long suspected the large species to be functionally blind, given the frequent presence of the parasite and its exceptionally dim and obstructed visual environment.

Now, new research from Skowronska-Krawczyk on Greenland shark vision – co-authored by University of Basel, Switzerland researchers Walter Salzburger and Lily G. Fogg, who worked on the evolutionary aspect of the study – is challenging what we know about aging, vision and longevity.

Published Jan. 5 in Nature Communications, her findings suggest that a DNA repair mechanism enables these sharks – some of which live for 400 years – to maintain their vision over centuries with no signs of retinal degeneration and that they are well adapted to extreme low-light conditions.

Skowronska-Krawczyk, who gleans insights into the molecular mechanisms of aging by studying processes that control age-related eye diseases, attributes her interest in the visual system of the Greenland shark to a 2016 research paper by John Fleng Steffensen published in the journal Science.

“One of my takeaway conclusions from the Science paper was that many Greenland sharks have parasites attached to their eyes – which could impair their vision,” she says. “Evolutionarily speaking, you don’t keep the organ that you don’t need. After watching many videos, I realized this animal is moving its eyeball toward the light.”

This left Skowronska-Krawczyk wanting to learn more.

The Greenland sharks used in her co-study were caught between 2020 and 2024 using scientific long lines off the coast of the University of Copenhagen’s Arctic Station on Disko Island, Greenland. Steffensen, professor of marine biology at the University of Copenhagen, and colleagues Peter G. Bushnell, who teaches at Indiana University South Bend, and Richard W. Brill, who’s based at the Virginia Institute of Marine Science, dissected and preserved the eyeballs in a fixative solution for examination.

Emily Tom, a UC Irvine Ph.D. student and physician-scientist in training who works in Skowronska-Krawczyk’s lab, recalls receiving the box that held a fixed eyeball.

“I opened the package, and there was a giant, 200-year-old eyeball sitting on dry ice just staring back at me,” the 28-year-old says with a laugh. “We’re used to working with mouse eyeballs, which are the size of a papaya seed, so we had to figure out how to scale up to a baseball-sized eyeball. Luckily, Dorota is very hands-on, both in her mentoring style and in the lab – which you don’t see a lot of with professors.”

Tom then let the eyeball defrost. “The lab smelled like a fish market,” she says.

She emphasizes that it was a careful balance of not letting it thaw too much because once tissue samples reach room temperature, they begin to degrade. Her role involved histological and vision-specific analyses of the eyeball, finding no signs of cell death, and revealing that rhodopsin (a protein essential for vision in dim light) in the shark retinas remains active and is tuned to detect blue light.

“Not a lot of people are working on sharks, especially shark vision,” Tom says. “We can learn so much about vision and longevity from long-lived species like the Greenland shark, so having the funds to do research like this is very important.”

For Skowronska-Krawczyk, the findings open the door to discovering new approaches to avoiding age-related vision loss and eradicating eye diseases such as macular degeneration and glaucoma – and to more questions about how vision evolves, the mechanisms that help keep tissues alive and healthy for many years, and how to apply this knowledge to humans.

She notes that with federal research funding under threat, future support for her studies is a concern, but she believes that “we will prevail.”

“What I love about my work is that we are the first in the world to see results – at the forefront, finding new mechanisms, rules and discoveries,” Skowronska-Krawczyk says, looking over at the paused shark on the screen. “Then, being able to share this joy with students – that’s the best part of it.”

About the University of California, Irvine: Founded in 1965, UC Irvine is a member of the prestigious Association of American Universities and is ranked among the nation’s top 10 public universities by U.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UC Irvine has more than 36,000 students and offers 224 degree programs. It’s located in one of the world’s safest and most economically vibrant communities and is Orange County’s second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. For more on UC Irvine, visit www.uci.edu. 


 

Bats identified as origin of unexplained acute respiratory illness and encephalitis in Bangladesh



Columbia University's Mailman School of Public Health




Infectious disease researchers have identified Pteropine orthoreovirus (PRV), an emerging bat-borne orthoreovirus, in archived throat swab samples and virus cultures from five patients in Bangladesh who were initially suspected to have Nipah virus infection but tested negative. This adds PRV to the list of zoonotic viruses detected in humans in Bangladesh and suggests that it should be considered in the differential diagnosis of Nipah-like illnesses. The study appears in the journal Emerging Infectious Diseases.

All five patients had recently consumed raw date-palm sap—a sweet liquid also enjoyed by bats, especially during winter months—and a known vector for Nipah infections in Bangladesh. Bats are the natural reservoir of numerous known and novel zoonotic viruses, including rabies, Nipah, Hendra, Marburg, and SARS-CoV-1.

“Our findings show that the risk of disease associated with raw date palm sap consumption extends beyond Nipah virus,” said Nischay Mishra, PhD, associate professor of epidemiology at the Center for Infection and Immunity (CII), Columbia University Mailman School of Public Health, and senior author of the study. “It also underscores the importance of broad-spectrum surveillance programs to identify and mitigate public health risks from emerging bat-borne viruses.”

Between December 2022 and March 2023, five patients were admitted with symptoms consistent with Nipah virus infection (including fever, vomiting, headache, fatigue, increased salivation, and neurological), but tested negative for Nipah virus by PCR and serology.  Researchers used high-throughput, agnostic viral capture sequencing (VCS) to analyze biological samples from the five patients and detected PRV sequences in archived throat swab specimens. PRV was also cultured from three of these samples, providing evidence of infectious virus.

Patients were enrolled under a Nipah virus surveillance program established by the Institute of Epidemiology, Disease Control and Research (IEDCR), Bangladesh; International Centre for Diarrheal Disease Research, Bangladesh (icddr,b); and U.S. Centers for Disease Control and Prevention (CDC).

Viral Capture Sequencing (VCS) is a patented technology developed in the CII at Columbia University to rapidly screen for all viral infections of vertebrates, including infections of bats. It is as sensitive as the gold-standard polymerase chain reaction (PCR) assays while enabling simultaneous testing for thousands of viruses and providing near-complete genome sequences. A correlate method, Bacterial Capture Sequencing (BCS), allows detection of pathogenic bacteria and genes for antimicrobial resistance. Both VCS and BCS are approved for clinical and research use.

All five patients experienced severe disease, although PRV infections reported elsewhere in neighboring countries have often been milder, suggesting that less severe cases in Bangladesh may be undetected.

“A new addition of zoonotic spillover causes respiratory and neurological complications following consumption of raw date palm sap next to Nipah virus infection,” says Tahmina Shirin, PhD, Director, Institute of Epidemiology, Disease Control, and Research (IEDCR), as well as the National Influenza Centre (NIC) in Bangladesh.

In a study conducted more recently that was supported by the U.S. Department of Agriculture, Mishra and colleagues identified the source of infections by identifying genetically similar Pteropine orthoreoviruses in bats captured in proximity to the five human cases near the Padma River Basin (unpublished data).

“This [research] provides critical evidence linking bat reservoirs to human infection. We are now working to understand the spillover mechanisms from bats to humans and domestic animals, as well as the broader ecology of emerging bat-borne viruses in communities along the Padma River Basin,” says Ariful Islam, bat-borne disease ecologist and epidemiologist at Charles Sturt University, Australia, and co-first author of the study.

The study’s co-first author is Sharmin Sultana, assistant professor of Virology and Senior Scientific Officer at the Institute of Epidemiology, Disease Control and Research (IEDCR) in Bangladesh. Additional authors include James Ng, Sunil Kumar Dubey, Cheng Guo, and W. Ian Lipkin of the CII; Manjur Hossain Khan at IEDCR in Bangladesh; Mohammed Ziaur Rahman and Moinuddin Satter at icddr,b in Bangladesh; Joel M. Montgomery at the CDC’s National Center for Emerging and Zoonotic Infectious Diseases; and  Lisa Hensley at the Zoonotic and Emerging Disease Research Unit, in the United States Department of Agriculture.

The research was supported with funds provided by United States Department of Agriculture agreements with Columbia University (NACA-58-3022-2-021, NACA- 58-3022-4-053).

The authors declare no conflicts

 

Researchers develop guidelines for diagnosing, monitoring canine cognitive decline




North Carolina State University






An international working group of canine cognition experts has released a set of guidelines for veterinarians to use in diagnosing and monitoring canine cognitive dysfunction syndrome (CCDS), or canine dementia. The guidelines offer a standard definition of the condition as well as practical diagnostic criteria and are meant to aid both clinicians and researchers in helping senior dogs with cognitive issues.

“We are seeing CCDS diagnoses with increasing frequency, but there isn’t a standardized method for the diagnosis,” says Natasha Olby, Dr. Kady M. Gjessing and Rahna M. Davidson Distinguished Chair in Gerontology at North Carolina State University. “We wanted to propose that standardized method as a starting point that can be built upon over time.” Olby is the leader of the working group and corresponding author of the work.

Similar to Alzheimer’s disease in humans, CCDS is defined as a chronic, progressive, age-associated neurodegenerative syndrome, characterized by cognitive and behavioral changes. These changes can include things like altered activity levels, sleep disruption, anxiety, house soiling, and learning and memory impairment.

“The good news here is that there is increased interest in finding treatments for CCDS,” Olby adds. “But in order to develop those treatments we must first be sure there’s an agreed upon definition of the condition.”

The group created a diagnostic flowchart to help veterinarians establish a diagnosis with two different levels of certainty, and they proposed three definitions of severity, ranging from mild to debilitating impairment.

The group recommends that veterinarians start monitoring dogs for cognitive changes via routine senior dog surveys when dogs are about 7 years old.

If behavioral abnormalities are reported by the caregiver, follow-up with a CCDS scale – a more detailed questionnaire – is recommended with ongoing monitoring every six months. Beginning at age 10 years, use of a CCDS scale every 6 months is recommended for all dogs.

The next steps are to rule out other ailments through physical and neurological exams, including brain imaging if possible.

The researchers hope providing a workable definition of CCDS and its diagnostic criteria will pave the way toward improved diagnostics and therapeutics.

“I selected the participants in this working group from experts in field who are either actively working on CCDS or who historically have set the standards – from those who first defined it to those who translated it into clinical practice,” Olby says. “We recognize that this document is just the start of the process, but it was developed as a working live document that can be added to over time as our understanding improves.”

The work appears in the Journal of the American Veterinary Medical Association and was supported in part by the American Kennel Club’s Canine Health Foundation (grant #03440).

-peake-

Note to editors: An abstract follows.

“The CCDS Working Group Guidelines for Diagnosis and Monitoring of Canine Cognitive Dysfunction Syndrome”

DOI: 10.2460/javma.25.10.0668

Authors: Natasha Olby, Margaret Gruen, North Carolina State University; Joseph A. Araujo, Transpharmation Canada, LTD; Phillipa Johnson, Cornell University; Eniko Kubinyi, ELTE Eötvös Loránd University, Budapest Hungary; Gary Landsberg, Veterinary Behaviour Consultant, Richmond Hill, ON, Canada; Caitlin S. Latimer, University of Washington, Seattle; Stephanie McGrath, Julie A. Moreno, Colorado State University; Brennen McKenzie, Loyal Animal Health, Inc.; Monica Tarantino, Senior Dog Veterinary Society, Alexandria, VA; Holger Volk, University of Veterinary Medicine, Hannover, Germany
Published: Dec. 24, 2025 in Journal of the American Veterinary Medical Association

Abstract:
Canine cognitive dysfunction syndrome (CCDS) is diagnosed with increasing frequency, yet standardized diagnostic guidelines are lacking. The CCDS Working Group, an international group combining experts in the field and primary care veterinarians, proposes a definition of the syndrome and practical diagnostic criteria designed to aid clinicians and researchers alike. CCDS is defined as a chronic, progressive, age-associated neurodegenerative syndrome, characterized by cognitive and behavioral changes that affect daily life to varying degrees. These changes affect the behavioral domains of disorientation, social interaction, sleep disruption, house soiling, learning and memory, activity changes, and anxiety (DISHAA). We propose three severity stages. In mild CCDS, signs are subtle, of low frequency or severity with preserved function. With progression, behavioral changes become more apparent and impactful, requiring management adjustments. In severe CCDS, debilitating deficits are overt, significantly impairing basic functions and necessitating comprehensive support. Two diagnostic levels are proposed. Level 1 is based on consistent history of progressive DISHAA signs, identification of alternate causes through physical, orthopedic and neurological examination and laboratory work, either normal neurological examination or evidence of symmetrical, diffuse forebrain dysfunction, and persistence of signs following management of relevant comorbidities. Level 2 includes a brain MRI showing cortical atrophy with cerebrospinal fluid (CSF) cell counts within normal limits. Definitive post-mortem histopathological confirmation rests on cortical atrophy, amyloid deposition, myelin loss, neuroinflammation, and amyloid angiopathy. Future priorities include the development of blood biomarkers and cognitive testing batteries for routine clinical settings, both of which will refine diagnostic accuracy and therapeutic monitoring.

 

Study examines how the last two respiratory pandemics rapidly spread through cities





Columbia University's Mailman School of Public Health





Public health researchers at Columbia University Mailman School of Public Health used computer modeling to reconstruct how the 2009 H1N1 flu pandemic and the 2020 COVID-19 pandemic unfolded in the U.S. The findings highlight the rapid spread of pandemic respiratory pathogens and the challenges of early outbreak containment. The study, published in the journal Proceedings of the National Academy of Sciences, is the first to comprehensively compare the spatial transmission of the last two respiratory pandemics in the U.S. at the metropolitan scale. 

In the U.S., the 2009 H1N1 flu pandemic was responsible for 274,304 hospitalizations and 12,469 deaths, and the 2020 COVID-19 pandemic has so far led to 1.2 million confirmed deaths.

The researchers set out understand the geographic spread of the two pandemics to inform strategies to prevent future pandemics. They applied detailed data on the dynamics of the two infectious diseases to a computer model to simulate their spread using known patterns of air travel and commuting, as well as potential superspreading events. They focused on over three hundred metropolitan areas in the U.S.

In the simulations, both pandemics were widely circulating in most of the metro areas within weeks, before government interventions or early case detection. While the specific transmission pathways across locations were different for the last two pandemics, the spatial expansion was driven by several shared transmission hubs such as the New York and Atlanta metropolitan areas. Their spread was largely driven by air travel rather than commuting, though random dynamics introduced substantial uncertainty in transmission routes, which makes it hard to predict where the outbreaks will happen in real time.

“The rapid and uncertain spread of the 2009 H1N1 flu and 2020 COVID-19 pandemics underscores the challenges for timely detection and control. Expanding wastewater surveillance coverage coupled with effective infection control could potentially slow the initial spread of future pandemics,” says the study’s senior author, Sen Pei, PhD, assistant professor of environmental health sciences at Columbia Mailman School. Many studies have pointed to the benefits of wastewater surveillance programs. The new study further underscores the benefit of expanding wastewater surveillance for pandemic preparedness.

Beyond reconstructing the historical spread of the last two pandemics, the study also provides a generalizable framework to infer early epidemic dynamics that may be applied to other pathogens. While mobility, particularly air travel, is a key driver of pandemic spread, the researchers caution that other factors also play a role, including community demographics, school schedules, winter holidays, and weather conditions.

The study’s first author is Renquan Zhang, Dalian University of Technology, Dalian, China. Additional authors include Rui Deng and Sitong Liu, Dalian University of Technology; Qing Yao and Jeffrey Shaman, Columbia University; Bryan T. Grenfell, Princeton; and Cécile Viboud, National Institutes of Health.

For more than a decade, Jeffrey Shaman and colleagues, including Sen Pei, have developed and refined methods to understand and simulate the spread of infectious diseases, including the flu, COVID-19, and others. Their real-time forecasts anticipate the rate and geographic spread of an outbreak, as well as the timing of its peak, to guide public health responses.

Shaman and Columbia University disclose partial ownership of SK Analytics. Other authors declare no competing interests.

This study was supported by funding from the National Natural Science Foundation of China (12371516), U.S. National Science Foundation (DMS-2229605), the Centers for Disease Control and Prevention (U01CK000592, 75D30122C14289), National Institute of Allergy and Infectious Diseases (R01AI163023), Princeton Catalysis Initiative, Princeton Precision Health, and High Meadows Environmental Institute. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. National Institutes of Health, Centers for Disease Control and Prevention, or Department of Health and Human Services.